ATE88352T1 - Humanes relaxinpraeparat. - Google Patents

Humanes relaxinpraeparat.

Info

Publication number
ATE88352T1
ATE88352T1 AT89902688T AT89902688T ATE88352T1 AT E88352 T1 ATE88352 T1 AT E88352T1 AT 89902688 T AT89902688 T AT 89902688T AT 89902688 T AT89902688 T AT 89902688T AT E88352 T1 ATE88352 T1 AT E88352T1
Authority
AT
Austria
Prior art keywords
human relaxin
composition
preparative
formulated
agent
Prior art date
Application number
AT89902688T
Other languages
English (en)
Inventor
David C Cipolla
Tue H Nguyen
Steven J Shire
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE88352T1 publication Critical patent/ATE88352T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/64—Relaxins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT89902688T 1988-02-26 1989-02-08 Humanes relaxinpraeparat. ATE88352T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16079788A 1988-02-26 1988-02-26
US30377989A 1989-01-27 1989-01-27
PCT/US1989/000502 WO1989007945A1 (en) 1988-02-26 1989-02-08 Human relaxin formulation

Publications (1)

Publication Number Publication Date
ATE88352T1 true ATE88352T1 (de) 1993-05-15

Family

ID=26857232

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89902688T ATE88352T1 (de) 1988-02-26 1989-02-08 Humanes relaxinpraeparat.

Country Status (14)

Country Link
US (2) US5451572A (de)
EP (1) EP0407401B1 (de)
JP (1) JP2815649B2 (de)
CN (1) CN1052655C (de)
AT (1) ATE88352T1 (de)
AU (1) AU626840B2 (de)
CA (1) CA1336403C (de)
DE (1) DE68906153T2 (de)
ES (1) ES2013394A6 (de)
IE (1) IE63208B1 (de)
IL (1) IL89276A (de)
NZ (1) NZ228012A (de)
PT (1) PT89835B (de)
WO (1) WO1989007945A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166191A (en) * 1991-08-19 1992-11-24 Genentech, Inc. Use of relaxin in cardiovascular therapy
US5478807A (en) * 1991-08-19 1995-12-26 Genentech, Inc. Use of relaxin in the treatment of bradycardia
JPH07508341A (ja) * 1991-10-28 1995-09-14 ボード・オヴ・リージェンツ，ザ・ユニヴァーシティ・オヴ・テキサス・システム 生物サンプルおよび体液中の正常細胞と悪性腫瘍細胞とにおける分化マーカーの検出方法
US5192743A (en) * 1992-01-16 1993-03-09 Genentech, Inc. Reconstitutable lyophilized protein formulation
US5830848A (en) * 1992-10-09 1998-11-03 The Regents Of The University Of California Method and agents for inducement of endogenous nitric oxide synthase for control and management of labor during pregnancy
WO1996011672A1 (fr) * 1994-10-13 1996-04-25 Wakamoto Pharmaceutical Co., Ltd. Preparation lyophilisee permettant d'obtenir une composition pharmaceutique a base d'eau se transformant de maniere reversible en gel sous l'effet de la chaleur
US5811395A (en) * 1995-06-07 1998-09-22 Medical University Of South Carolina Relaxin analogs and derivatives methods and uses thereof
AU6777196A (en) 1995-08-15 1997-03-12 Connective Therapeutics Inc. Method of promoting angiogenesis
US5612051A (en) * 1995-11-17 1997-03-18 Yue; Samuel K. Method of treating involuntary muscle dysfunction with relaxin hormone
EP0852951A1 (de) 1996-11-19 1998-07-15 Roche Diagnostics GmbH Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
US5994148A (en) * 1997-06-23 1999-11-30 The Regents Of University Of California Method of predicting and enhancing success of IVF/ET pregnancy
US6251863B1 (en) 1998-09-08 2001-06-26 Samuel K. Yue Method of preventing and treating symptoms of aging and neurodegenerative dysfunctions with relaxin
AU781537B2 (en) * 1998-12-18 2005-05-26 Palladin Healthcare International, Ltd. Composition for treatment of burns
EP1253929B1 (de) * 2000-02-09 2007-05-23 BAS Medical, Inc. Verwendung von relaxin zur behandlung von durch gefässverengung bedingten erkrankungen
US20050032683A1 (en) 2000-10-04 2005-02-10 Amento Edward P. Methods of modulating apoptosis by administration of relaxin agonists or antagonists
US20040156835A1 (en) * 2001-05-30 2004-08-12 Taiji Imoto Protein preparation
US20100134794A1 (en) * 2004-02-05 2010-06-03 Medpro Holdings, Llc Analyzer for determining the concentration, potency and purity of pharmaceutical compounds
US7660678B2 (en) * 2004-02-05 2010-02-09 Medpro Holdings, Llc On-site method of providing analysis of potency and purity of pharmaceutical compounds
US7878978B2 (en) 2004-03-18 2011-02-01 University Of Pittsburgh- Of The Commonwealth System Of Higher Education Use of relaxin to increase arterial compliance
JP4836942B2 (ja) * 2004-04-30 2011-12-14 コーセラ， インコーポレイテッド リラキシンの調節による胎仔の発育の制御のための方法および組成物
WO2006020580A2 (en) * 2004-08-09 2006-02-23 Alios Biopharma Inc. Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same
US7597884B2 (en) 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
US20060052304A1 (en) * 2004-09-02 2006-03-09 Bas Medical, Inc. Method for remodeling bone and related sutures
US20080241260A1 (en) * 2005-09-28 2008-10-02 Padma Venkitachalam Devarajan Compositions for Enhanced Absorption of Biologically Active Agents
EP2288367B1 (de) * 2008-05-16 2015-10-07 Corthera, Inc. H2-Relaxin zur Verwendung bei der Behandlung von vorzeitiger Zervixdilatation
EP2278993A4 (de) * 2008-05-16 2012-09-12 Corthera Inc Verfahren zur förderung von wundheilung
EP2405933A1 (de) * 2009-03-13 2012-01-18 Medtronic, Inc Verfahren zur behandlung von herzinsuffizienz
WO2011112791A1 (en) * 2010-03-10 2011-09-15 Corthera, Inc Modulating aquaporins with relaxin
HUE045845T2 (hu) 2010-08-17 2021-12-28 Ambrx Inc Módosított relaxin polipeptidek és felhasználásuk
CN102133200B (zh) * 2011-03-16 2012-07-25 济南环肽医药科技有限公司 一种人类松弛素-2 Relaxin的注射用冻干粉制剂
US9393288B2 (en) 2012-05-29 2016-07-19 The University Of Vermont And State Agricultural College Methods of treating diseases associated with PPARγ
CN103768584A (zh) * 2014-02-10 2014-05-07 济南环肽医药科技有限公司 一种松弛肽注射液
CN104922661B (zh) * 2014-03-20 2018-08-24 深圳翰宇药业股份有限公司 一种含有serelaxin的药物组合物及其制备方法
WO2016059593A1 (en) * 2014-10-16 2016-04-21 Piramal Enterprises Limited Stable injectable composition of protein drugs and process for its preparation
CN107007822A (zh) * 2016-01-27 2017-08-04 江苏恒瑞医药股份有限公司 一种含有重组人松弛素‑2类似物的药物组合物及其制备方法
CA3052639A1 (en) 2017-02-08 2018-08-16 Bristol-Myers Squibb Company Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
WO2018182562A1 (en) * 2017-03-26 2018-10-04 Stafford Vivi Robyn Method of treatment of skin conditions of eye lids

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2964448A (en) * 1959-01-27 1960-12-13 Anschel Joachim Relaxin composition and process for preparing same
US3003117A (en) * 1959-09-29 1961-10-03 Gen Frecision Inc Coincident frequency tracker
US3962416A (en) * 1971-01-25 1976-06-08 Sol Katzen Preserved nutrients and products
EP0018609B1 (de) * 1979-04-30 1983-09-21 Hoechst Aktiengesellschaft Gegen Denaturierung beständige, wässrige Protein-Lösungen, Verfahren zu ihrer Herstellung und ihre Verwendung
US4267101A (en) * 1980-02-01 1981-05-12 Serono Laboratories Inc. Process for obtaining human relaxin from fetal membranes
EP0080879B1 (de) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Stabilisiertes Interferon enthaltende pharmazeutische Zusammensetzung
EP0101309B1 (de) * 1982-08-12 1991-01-16 Howard Florey Institute Of Experimental Physiology And Medicine Molekulare Klonierung und Charakterisierung der das menschliche Relaxin kodierenden Gen-Sequenz
DE3236264A1 (de) * 1982-09-30 1984-04-05 Serono Pharmazeutische Präparate GmbH, 7800 Freiburg Verfahren zur gewinnung von relaxin
DE3236267A1 (de) * 1982-09-30 1984-04-05 Serono Pharmazeutische Präparate GmbH, 7800 Freiburg Verfahren zur herstellung von relaxin und verfahren zur hochreinigung von relaxin
IL70414A (en) * 1982-12-13 1991-06-10 Florey Howard Inst Polypeptide having human h2-relaxin activity,double-stranded dna fragments coding therefor,vectors containing the dna fragments and methods for preparing the polypeptide,dna fragments and vectors
CH661662A5 (en) * 1984-04-16 1987-08-14 Georg L Prof Dr Floersheim Product for the treatment of the skin and of the connective tissue
US4605555A (en) * 1984-09-20 1986-08-12 Sun Star Kabushiki Kaisha Composition and method for treating keratosic disorder of skin and mucosa
US4806343A (en) * 1986-03-13 1989-02-21 University Of Southwestern Louisiana Cryogenic protectant for proteins
NZ221789A (en) * 1986-09-12 1991-05-28 Genentech Inc Recombinant prorelaxin, its preparation and pharmaceutical compositions comprising it
US4717717A (en) * 1986-11-05 1988-01-05 Ethicon, Inc. Stabilized compositions containing epidermal growth factor

Also Published As

Publication number Publication date
IL89276A (en) 1994-06-24
US5451572A (en) 1995-09-19
PT89835A (pt) 1989-10-04
US5945402A (en) 1999-08-31
JP2815649B2 (ja) 1998-10-27
AU3183389A (en) 1989-09-22
NZ228012A (en) 1991-07-26
IE63208B1 (en) 1995-04-05
EP0407401B1 (de) 1993-04-21
EP0407401A1 (de) 1991-01-16
WO1989007945A1 (en) 1989-09-08
AU626840B2 (en) 1992-08-13
PT89835B (pt) 1994-01-31
JPH03502794A (ja) 1991-06-27
CN1035619A (zh) 1989-09-20
CN1052655C (zh) 2000-05-24
IE890452L (en) 1989-08-26
DE68906153T2 (de) 1993-10-28
CA1336403C (en) 1995-07-25
ES2013394A6 (es) 1990-05-01
DE68906153D1 (de) 1993-05-27
IL89276A0 (en) 1989-09-10

Similar Documents

Publication Publication Date Title
ATE88352T1 (de) Humanes relaxinpraeparat.
MX9602259A (es) Proteina modificada quimicamente en el nitrogeno terminal, composiciones que las incluyen y metodos para su preparacion.
ES2104605T3 (es) Composiciones estables de acido ascorbico.
MY101791A (en) New benzimidazole derivatives
ATE83927T1 (de) Thrombinzusammensetzung.
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
GR3005035T3 (de)
ZA895090B (en) Novel benzopyran derivatives,processes for their preparation and their use and preparations containing the compounds
DE3686136D1 (de) Fibrinolytisches agens.
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
DK193887A (da) Peptid med bronchodilartorisk og hypotensiv aktivitet
DE3173954D1 (en) Use of adenosin derivatives for the manufacture of psychopharmacons
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
ES2016464A6 (es) Procedimiento para preparar derivados de 2', 5' -oligoadenilato.
ATE47518T1 (de) Injizierbare pharmazeutische zusammenstellungen die bestaendige 5-adenosyl-l-methionin-salze enthalten.
FI913909A0 (fi) t-PA pro:n stabilointi
EP0373613A3 (de) Pyridin-3-percarboxylsäure monopersulfat
ZA873928B (en) Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease
MY103952A (en) Aqueous formulations containing a piperidinylcyclopentyheptenoic acid derivative
ATE36957T1 (de) N,n-diethyl-5-methyl-2h,1-benzothiopyrano-(4,3, - cd)-indazol-2-ethanamine, diese enthaltende zubereitungen und ihre verwendung.
ATE102934T1 (de) Fluorierte flavon-essigsaeure.
RO85674B1 (ro) Biocomplex fiziologic activ
FR2628422B1 (fr) Le sel de sodium monohydrate de la 1,2- diphenyl-3,5-dioxo-4-n-butylpyrazolidine (" phenylbutazone ") et sa preparation
IL88836A0 (en) Method of obtaining antivirally active proteins,antivirally active proteins and compositions containing them
IL92429A0 (en) Method of obtaining antivirally active proteins,antivirally active proteins and compositions containing them

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee